HCW Biologics (HCWB) Change in Receivables (2021 - 2025)
HCW Biologics' (HCWB) quarterly Change in Receivables came in at $1508.0 in Q4 2025, up 102.17% YoY from $745.92 in Q4 2024, and down 83.35% on a QoQ basis from $9056.0 in Q3 2025.
HCW Biologics (HCWB) Change in Receivables (2021 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 5 years of Change in Receivables data on file, last reported at $1508.0 in Q4 2025.
- Quarterly Change in Receivables rose 102.17% year-over-year to $1508.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$550026.0 (up 42.32% YoY) and the FY2025 annual result came in at -$550026.0, up 42.32% from the prior year.
- Change in Receivables eased to $1508.0 in Q4 2025, from $9056.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $825678.0 in Q4 2023 to a low of -$1.2 million in Q2 2021.
- A 5-year average of -$123391.3 and a median of -$812.5 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables surged 1228.74% — and 2024, when it plunged 283.03%.
- Tracing HCWB's Change in Receivables over 5 years: stood at $63000.0 in 2021, then slipped by 1.37% to $62140.0 in 2022, then surged by 1228.74% to $825678.0 in 2023, then slumped by 108.43% to -$69639.0 in 2024, then surged by 102.17% to $1508.0 in 2025.
- The last three Change in Receivables figures came in at $1508.0 (Q4 2025), $9056.0 (Q3 2025), and -$65882.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,508.00 |
| Dec 31, 2025 | 1,508.00 |
| Sep 30, 2025 | 9,056.00 |
| Sep 30, 2025 | 9,056.00 |
| Jun 30, 2025 | -65,882.00 |
| Jun 30, 2025 | -65,882.00 |
| Mar 31, 2025 | -494,708.00 |
| Mar 31, 2025 | -494,708.00 |
| Dec 31, 2024 | -69,639.00 |
| Dec 31, 2024 | -69,639.00 |
| Sep 30, 2024 | -3,133.00 |
| Sep 30, 2024 | -3,133.00 |
| Jun 30, 2024 | -248,911.00 |
| Jun 30, 2024 | -248,911.00 |
| Mar 31, 2024 | -631,873.00 |
| Mar 31, 2024 | -631,873.00 |
| Dec 31, 2023 | 825,678.00 |
| Dec 31, 2023 | 825,678.00 |
| Sep 30, 2023 | 2,867.00 |
| Sep 30, 2023 | 2,867.00 |